HELP Therapeutics Information

HELP Therapeutics is a pioneering biotechnology company dedicated to revolutionizing the treatment of degenerative diseases through stem cell and regenerative medicine technologies. Established in 2016, our mission is to develop iPSC-based cell therapies that provide innovative solutions for patients with unmet medical needs. Our core technology platforms are built around allogeneic iPSC-derived cell therapy and a fully automated cell manufacturing system, enabling us to deliver highly effective and accessible therapies to a broader range of patients. Recent successes include securing US FDA and China NMPA clearances for our Investigational New Drug (IND) applications of HiCM-188 cell therapy to treat end-stage heart failure, marking significant milestones in our journey. At HELP Therapeutics, we believe in the power of science to transform lives. Our dedicated team of scientists, researchers, and medical professionals is committed to advancing the field of regenerative medicine and bringing hope to patients facing degenerative diseases.